Related Experiment Video
Updated: Dec 21, 2025

11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
10.4K
Multivalent manganese complex decorated amphiphilic dextran micelles as sensitive MRI probes
Changqiang Wu1, Danyang Li, Li Yang
1National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, P. R. China. huaai@scu.edu.cn.
Journal of Materials Chemistry. B
|May 21, 2020
Summary
Researchers developed manganese(II)-based T1 contrast agents using nanomicelles. These agents show improved relaxivity and vascular enhancement at lower manganese doses, offering a more sensitive and effective MRI contrast agent.
Area of Science:
- Biomedical Engineering
- Materials Science
- Radiology
Background:
- T1 contrast agents are crucial for Magnetic Resonance Imaging (MRI).
- Manganese(II) complexes offer paramagnetic properties for T1 MRI.
- Developing stable and effective manganese-based contrast agents remains an area of active research.
Purpose of the Study:
- To conjugate manganese(II) onto amphiphilic dextran micelles.
- To evaluate the T1 relaxivity and sensitivity of the novel nanomicelle contrast agent.
- To assess the in vivo vascular enhancement effect and manganese dosage.
Main Methods:
- Amphiphilic dextran micelles were synthesized.
- Manganese(II) was conjugated to the micelles using click chemistry.
- T1 relaxivity measurements were performed.
- In vivo studies were conducted to evaluate vascular enhancement.
Main Results:
- The nanomicelle contrast agent exhibited higher T1 relaxivity (13.3 Mn mmol⁻¹ s⁻¹) compared to free Mn(II) complexes.
- Enhanced sensitivity was observed with the nanomicelle formulation.
- In vivo studies demonstrated a superior and long-acting vascular enhancement effect.
- Effective enhancement was achieved at a low manganese dosage (0.1 Mn mmol kg⁻¹ BW).
Conclusions:
- Conjugating Mn(II) onto amphiphilic dextran micelles via click chemistry yields a highly effective T1 contrast agent.
- The nanomicelle agent offers improved performance and reduced manganese dosage for in vivo MRI.
- This approach presents a promising strategy for developing advanced manganese-based MRI contrast agents.

